ÔçÒÒŮѸÀ×

    • <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      
    

    

      Haemonetics Corp.
      Haemonetics Corp.
      HAE
      Market Cap$2.63B
       Close$
      
      
      
      
      Compare to Similar Companies
      P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
      Haemonetics Corp.Haemonetics Corp.16.1-19%21.4
      $68.00
      Target Price by Analysts
      25.7% upsideHaemonetics Target Price DetailsTarget Price
      $169.08
      Current Fair Value
      212.6% upside
      Undervalued by 212.6% based on the discounted cash flow analysis.
      Share Statistics
      Market cap$2.63 Billion
      Enterprise Value$3.61 Billion 
      Dividend Yield$- (-)
      Earnings per Share$3.31 
      Beta0.4
      Outstanding Shares48,111,000
      Return
      Return on Equity-
      Return on Assets-
      Return on Invested Capital-
      Valuation & Multiples
      P/E Ratio16.06
      PEG-141.97
      Price to Sales2.0
      Price to Book Ratio3.0
      Enterprise Value to Revenue2.68
      Enterprise Value to EBIT15.6
      Enterprise Value to Net Income22
      Total Debt to Enterprise0.35
      Debt to Equity1.44
      Revenue Sources
      No data
      Insider Trades
      ESG Score
      No data
      About Haemonetics Corp.
      CEO: Christopher Simon 
      
      
      


    
      
  
      
    

    
  
      

      

    
      
  To improve your user experience we use
  cookies.
  

      

    
  
  
      
  
      

  
  

  

  
  

  
HoMEÔçÒÒŮѸÀ×